10/19/2020 Database Update: Audit of Veterinary Drug Retail Sales in Russia (September and Q1 – Q3 2020)
Between January and September 2020, the stagnating sales of veterinary drugs in the retail market amounted to RUB 15.97 bln (retail prices, VAT included), which is in monetary terms (rubles) 0.3% lower than in 2019. The volume in physical terms is 144.4 bln minimum dosage units (MDU), which is 0.3% higher than in 2019.
Between January and August 2020, Russia imported RUB 20.9 bln worth of veterinary drugs (customs clearance and VAT included), which is in monetary terms (rubles) 4% higher than in 2019. The import volume of feed supplements amounted to RUB 27.2 mln, with the dynamics of +14%.
10/15/2020 API Import to Russia (August 2020)
Between January and August 2020, Russia imported RUB 110.1 bln worth of APIs (customs clearance and VAT included), which is in monetary terms (rubles) 29% higher than in 2019. The dynamics in physical terms (tons) are +18%, with the import volume of 9.8 thousand tons.
Between January and August 2020, Russia imported RUB 314 bln worth of ready-made drugs (customs clearance and VAT included), which is in monetary terms (rubles) 21% lower than in 2019. This year the import dynamics are practically determined by administrative procedures associated with the launch of the labeling system, not so much by the demand situation since the launch has completely changed the usual seasonal behavior of participants in foreign economic activity for most of the mass-market drugs. These trends were much less relevant for in-bulk drugs, with the dynamics of +17.4% in monetary terms and the import volume of RUB 89.4 bln.
The online segment includes a wide variety of platforms, many of which sell beauty and health products. These are marketplaces such as www.iHerb.com and others, electronics and household appliances stores, as well as official online stores of companies, for example www.shop.philips.ru. Despite the product range overlapping with that of pharmacies, many of the online retailers still operate outside the pharmaceutical market as such and do not enter into direct competition with the pharmaceutical retail, while often influencing consumption trends, given the scale of certain players.